How Do Hospitals Respond to Price Changes? (WP-03-17)
Leemore DafnyThis paper investigates whether hospitals respond in profit-maximizing ways to changes in diagnosis-specific prices, as determined by Medicare’s Prospective Payment System and other public and private insurers. Previous studies have been unable to isolate this response because changes in reimbursement amounts (prices) are typically endogenous: They are adjusted to reflect changes in hospital costs. Dafny exploits an exogenous 1988 policy change that generated large price changes for 43 percent of all Medicare admissions. She finds hospitals responded to these price changes by “upcoding” patients to diagnosis codes associated with large reimbursement increases, garnering $330-$425 million in extra reimbursements annually. This response was particularly strong among for-profit hospitals. With the important exception of elective diagnoses, she sees little evidence that hospitals increased the intensity of care in diagnoses subject to price increases, where intensity is measured by total costs, length of stay, number of surgical procedures, and number of intensive-care-unit days. Neither did hospitals increase the volume of patients admitted to more remunerative diagnoses, notwithstanding the strong a priori expectation that such a response should prevail in fixed-price settings. Taken together, these findings suggest, for the most part, that hospitals do not alter their treatment or admissions policies based on diagnosis-specific prices; however, they employ sophisticated coding strategies to maximize total reimbursement. The results also suggest models of quality competition among hospitals might be inappropriate at the level of specific diagnoses (“products”).
Leemore Dafny, Assistant Professor of Management and Strategy, Kellogg School of Management and Institute for Policy Research, Northwestern University; and NBER